Skip to main content

Advertisement

SpringerLink
Log in

Screening and referral for axial spondyloarthritis—need of the hour

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Although axial spondyloarthritis (axSpA) is as prevalent as rheumatoid arthritis, it is commonly under recognized due to variety of reasons. AxSpA contributes to significant loss of function and disability among young adults. With the availability of newer assessment methods and effective therapeutic agents, early diagnosis and appropriate treatment are possible. As mechanical back pain is widely prevalent in general population, selection of patients with high likelihood of having axSpA and referral to rheumatologists is very important to allow prompt diagnosis and management of axSpA yet avoid improper utilization of resources. Various referral strategies have been developed for this purpose which have included patients with chronic back pain for >3 months with age of onset <45 years and one or more typical spondyloarthritis features with high sensitivity and specificity. Consistent application of both simple and complex strategies has demonstrated similar results in various clinical studies. About 35–45 % of patients referred to rheumatologists using these strategies were finally diagnosed to have axSpA. Potential referring providers include primary care physicians, physical therapists, orthopedic and spine surgeons, chiropractors, rehabilitation medicine physicians, ophthalmologists, gastroenterologists, and dermatologists. Increasing the awareness and education of the referring providers are two very important steps in the success of the referral strategy. With proper application of any strategy described below, a rheumatologist will need to see two to three patients with chronic back pain to identify one patient with axSpA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60(4):353–358

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58–67

    Article  CAS  PubMed  Google Scholar 

  3. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25

    Article  PubMed  Google Scholar 

  4. Liao ZT, Pan YF, Huang JL, Huang F, Chi WJ, Zhang KX et al (2009) An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population. Scand J Rheumatol 38(6):455–459

    Article  CAS  PubMed  Google Scholar 

  5. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  PubMed  Google Scholar 

  6. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783

    Article  CAS  PubMed  Google Scholar 

  7. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66

    PubMed  Google Scholar 

  8. Boyer GS, Templin DW, Bowler A, Lawrence RC, Everett DF, Heyse SP et al (1997) A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us? Arch Intern Med 157(18):2111–2117

    Article  CAS  PubMed  Google Scholar 

  9. Jois RN, Macgregor AJ, Gaffney K (2008) Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatology (Oxford) 47(9):1364–1366

    Article  CAS  Google Scholar 

  10. van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52(2):582–591

    Article  PubMed  Google Scholar 

  11. van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J et al (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54(7):2136–2146

    Article  PubMed  Google Scholar 

  12. Inman RD, Davis JC Jr, Heijde D, Diekman L, Sieper J, Kim SI et al (2008) Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 58(11):3402–3412

    Article  CAS  PubMed  Google Scholar 

  13. Landewe R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ et al (2014) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis 73(1):39–47

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH et al (2013) The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645–2654

    PubMed Central  CAS  PubMed  Google Scholar 

  15. Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382(9906):1705–1713

    Article  CAS  PubMed  Google Scholar 

  16. Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J (2014) Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 73(5):817–823

    Article  CAS  PubMed  Google Scholar 

  17. Haibel H, Rudwaleit M, Listing J, Heldmann F, Wong RL, Kupper H et al (2008) Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 58(7):1981–1991

    Article  CAS  PubMed  Google Scholar 

  18. Barkham N, Keen HI, Coates LC, O’Connor P, Hensor E, Fraser AD et al (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60(4):946–954

    Article  CAS  PubMed  Google Scholar 

  19. Song IH, Hermann K, Haibel H, Althoff CE, Listing J, Burmester G et al (2011) Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 70(4):590–596

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Walker BF (2000) The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord 13(3):205–217

    Article  CAS  PubMed  Google Scholar 

  21. Nielens H, Van Zundert J, Mairiaux P, Gailly J, Van Den Hecke N, Mazina D et al (2006) Chronic low backpain. Good Clinical practice (GCP). Belgian Health Care Knowledge Centre (KCE), Brussels. KCE reports 48 C (D/2006/10.273/71)

  22. Underwood MR, Dawes P (1995) Inflammatory back pain in primary care. Br J Rheumatol 34(11):1074–1077

    Article  CAS  PubMed  Google Scholar 

  23. Brandt HC, Spiller I, Song IH, Vahldiek JL, Rudwaleit M, Sieper J (2007) Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis 66(11):1479–1484

    Article  PubMed Central  PubMed  Google Scholar 

  24. Hermann J, Giessauf H, Schaffler G, Ofner P, Graninger W (2009) Early spondyloarthritis: usefulness of clinical screening. Rheumatology (Oxford) 48(7):812–816

    Article  Google Scholar 

  25. Braun A, Saracbasi E, Grifka J, Schnitker J, Braun J (2011) Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain? Ann Rheum Dis 70(10):1782–1787

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Poddubnyy D, Vahldiek J, Spiller I, Buss B, Listing J, Rudwaleit M et al (2011) Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care. J Rheumatol 38(11):2452–2460

    Article  PubMed  Google Scholar 

  27. Sieper J, Srinivasan S, Zamani O, Mielants H, Choquette D, Pavelka K et al (2013) Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis 72(10):1621–1627

    Article  PubMed  Google Scholar 

  28. van den Berg R, de Hooge M, van Gaalen F, Reijnierse M, Huizinga T, van der Heijde D (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52(8):1492–1499

    Article  Google Scholar 

  29. Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2010 summary tables. http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf.

  30. Weisman MH, Witter JP, Reveille JD (2013) The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009–10. Ann Rheum Dis 72(3):369–373

    Article  PubMed Central  PubMed  Google Scholar 

  31. Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH (2012) The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum 64(5):1407–1411

    Article  PubMed Central  PubMed  Google Scholar 

  32. Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM (2013) Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res 65(8):1299–1306

    Article  Google Scholar 

  33. Masi AT, Wilkins WR (1996) Does male: female sex ratio in ankylosing spondylitis change with age? J Rheumatol 23(5):947–948

    CAS  PubMed  Google Scholar 

  34. Lee W, Reveille JD, Davis JC Jr, Learch TJ, Ward MM, Weisman MH (2007) Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 66(5):633–638

    Article  PubMed Central  PubMed  Google Scholar 

  35. Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C et al (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 64(9):1415–1422

    Article  Google Scholar 

  36. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H et al (2011) Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 70(8):1369–1374

    Article  PubMed  Google Scholar 

  37. Baron M, Zendel I (1989) HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. J Rheumatol 16(5):631,4, discussion 634–6

    Google Scholar 

  38. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63(5):535–543

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4):573

    Article  PubMed  Google Scholar 

  40. van der Heijde D, Sieper J, Elewaut D, Deodhar A, Pangan AL, Dorr AP (2014) Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey. J Clin Rheumatol 20(8):411–417

    Article  PubMed Central  PubMed  Google Scholar 

  41. Deodhar A, Mease PJ, Reveille JD, Curtis JR, Karunaratne PM, Malhotra K, Pangan AL (2014) Prevalence of axial spondyloarthritis among undiagnosed chronic back pain patients in the United States [abstract]. Ann Rheum Dis 73(Suppl2):198–199

    Article  Google Scholar 

  42. Braun J, Inman R (2010) Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 69(7):1264–1268

    Article  PubMed  Google Scholar 

  43. Thom N, Ritchlin CT, Zhang X, Reveille J, Weisman MH (2014) Prevalence of chronic axial pain, inflammatory back pain and spondyloarthritis in diagnosed psoriasis. Arthritis Care Res. doi:10.1002/acr.22528

  44. van Onna M, Gorter S, van Meerendonk A, van Tubergen A (2014) General practitioners’ perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: a qualitative study. J Rheumatol 41(5):897–901

    Article  PubMed  Google Scholar 

  45. Harrison AA, Badenhorst C, Kirby S, White D, Athens J, Stebbings S (2014) Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign. Clin Rheumatol 33(7):963–968

    Article  PubMed  Google Scholar 

Download references

Source and grants

None

Author information

Authors and Affiliations

  1. Division of Rheumatology, University of Nebraska Medical Center, 983025 Nebraska Medical Center, Omaha, NE, 68198-3025, USA

    Abhijeet Danve

  2. Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, Oregon, 97239, USA

    Atul Deodhar

Authors
  1. Abhijeet Danve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul Deodhar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abhijeet Danve.

Additional information

Final manuscript has been approved by all the authors, and they confirm the integrity of the work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Danve, A., Deodhar, A. Screening and referral for axial spondyloarthritis—need of the hour. Clin Rheumatol 34, 987–993 (2015). https://doi.org/10.1007/s10067-015-2958-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2958-2

Keywords

Search

Navigation